Ritalin: Antiasthenic Effect of Methylphenidate (Ritalin) in Palliative Care in Cancer Patients
Status:
Terminated
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The aim/objective of this study is to evaluate the antiasthenic effect of methylphenidate
with a visual analogical scale (VAS) after 7 days of treatment, in cancer patients, in
palliative care, i.e. with a progressive or terminal disease.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Grenoble
Collaborators:
Fondation de France Ligue contre le cancer, France